<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p125" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_125{left:36px;bottom:778px;letter-spacing:-0.14px;word-spacing:0.04px;}
#t2_125{left:36px;bottom:760px;letter-spacing:-0.1px;}
#t3_125{left:36px;bottom:742px;letter-spacing:-0.1px;}
#t4_125{left:36px;bottom:723px;letter-spacing:-0.09px;}
#t5_125{left:42px;bottom:684px;letter-spacing:-0.13px;word-spacing:0.03px;}
#t6_125{left:42px;bottom:660px;letter-spacing:-0.1px;}
#t7_125{left:42px;bottom:635px;letter-spacing:-0.14px;}
#t8_125{left:134px;bottom:635px;letter-spacing:-0.1px;}
#t9_125{left:42px;bottom:611px;letter-spacing:-0.12px;}
#ta_125{left:134px;bottom:611px;letter-spacing:-0.09px;}
#tb_125{left:42px;bottom:587px;letter-spacing:-0.12px;}
#tc_125{left:134px;bottom:587px;letter-spacing:-0.08px;}
#td_125{left:134px;bottom:568px;letter-spacing:-0.11px;}
#te_125{left:42px;bottom:544px;letter-spacing:-0.12px;}
#tf_125{left:134px;bottom:544px;letter-spacing:-0.08px;}
#tg_125{left:134px;bottom:525px;letter-spacing:-0.09px;word-spacing:-0.02px;}
#th_125{left:377px;bottom:525px;letter-spacing:-0.09px;}
#ti_125{left:397px;bottom:525px;letter-spacing:-0.08px;word-spacing:-0.02px;}
#tj_125{left:134px;bottom:507px;letter-spacing:-0.09px;}
#tk_125{left:134px;bottom:489px;letter-spacing:-0.09px;}
#tl_125{left:153px;bottom:489px;letter-spacing:-0.08px;}
#tm_125{left:134px;bottom:470px;letter-spacing:-0.1px;}
#tn_125{left:89px;bottom:446px;letter-spacing:-0.12px;}
#to_125{left:134px;bottom:446px;letter-spacing:-0.25px;}
#tp_125{left:134px;bottom:428px;letter-spacing:-0.26px;}
#tq_125{left:89px;bottom:403px;letter-spacing:-0.12px;}
#tr_125{left:134px;bottom:403px;letter-spacing:-0.08px;}
#ts_125{left:134px;bottom:385px;letter-spacing:-0.1px;}
#tt_125{left:89px;bottom:360px;letter-spacing:-0.12px;}
#tu_125{left:134px;bottom:360px;letter-spacing:-0.08px;}
#tv_125{left:134px;bottom:342px;letter-spacing:-0.1px;}
#tw_125{left:42px;bottom:318px;letter-spacing:-0.12px;}
#tx_125{left:134px;bottom:318px;letter-spacing:-0.09px;}
#ty_125{left:134px;bottom:299px;letter-spacing:-0.09px;}
#tz_125{left:153px;bottom:299px;letter-spacing:-0.09px;}
#t10_125{left:89px;bottom:275px;letter-spacing:-0.12px;}
#t11_125{left:134px;bottom:275px;letter-spacing:-0.09px;}
#t12_125{left:89px;bottom:250px;letter-spacing:-0.12px;}
#t13_125{left:134px;bottom:250px;letter-spacing:-0.09px;}
#t14_125{left:36px;bottom:216px;letter-spacing:0.11px;}
#t15_125{left:77px;bottom:216px;letter-spacing:0.11px;word-spacing:0.01px;}
#t16_125{left:36px;bottom:199px;letter-spacing:0.12px;}
#t17_125{left:36px;bottom:182px;letter-spacing:0.11px;word-spacing:0.02px;}
#t18_125{left:36px;bottom:73px;letter-spacing:0.12px;word-spacing:-0.08px;}
#t19_125{left:36px;bottom:56px;letter-spacing:0.12px;}
#t1a_125{left:880px;bottom:56px;letter-spacing:0.03px;}
#t1b_125{left:1004px;bottom:56px;letter-spacing:0.08px;}
#t1c_125{left:1091px;bottom:111px;letter-spacing:-0.11px;}
#t1d_125{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t1e_125{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t1f_125{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t1g_125{left:341px;bottom:30px;}
#t1h_125{left:348px;bottom:25px;letter-spacing:0.11px;}
#t1i_125{left:377px;bottom:30px;}
#t1j_125{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t1k_125{left:540px;bottom:30px;}
#t1l_125{left:546px;bottom:25px;letter-spacing:0.07px;}
#t1m_125{left:996px;bottom:873px;letter-spacing:-0.1px;}
#t1n_125{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#t1o_125{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#t1p_125{left:1138px;bottom:28px;letter-spacing:-0.12px;}
#t1q_125{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_125{font-size:17px;font-family:Arial-BoldItalicMT_kg;color:#000;}
.s1_125{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s2_125{font-size:17px;font-family:ArialMT_k0;color:#000;}
.s3_125{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s4_125{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s5_125{font-size:15px;font-family:Arial-ItalicMT_kb;color:#000;}
.s6_125{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s7_125{font-size:15px;font-family:ArialMT_k0;color:#000;}
.s8_125{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s9_125{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sa_125{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_125{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.sc_125{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.sd_125{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.se_125{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts125" type="text/css" >

@font-face {
	font-family: Arial-BoldItalicMT_kg;
	src: url("fonts/Arial-BoldItalicMT_kg.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg125Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg125" style="-webkit-user-select: none;"><object width="1210" height="935" data="125/125.svg" type="image/svg+xml" id="pdf125" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_125" class="t s0_125">Table 3 — Continued </span>
<span id="t2_125" class="t s1_125">American Joint Committee on Cancer (AJCC) </span>
<span id="t3_125" class="t s1_125">TNM Staging System for the Oropharynx (p16-) and Hypopharynx (8th ed., 2017) </span>
<span id="t4_125" class="t s2_125">(Not included: P16-positive (p16+) oropharyngeal cancers and nasopharyngeal cancer) </span>
<span id="t5_125" class="t s1_125">Regional Lymph Nodes (N) </span>
<span id="t6_125" class="t s1_125">Clinical N (cN) - Oropharynx (p16-) and Hypopharynx </span>
<span id="t7_125" class="t s1_125">NX </span><span id="t8_125" class="t s3_125">Regional lymph nodes cannot be assessed </span>
<span id="t9_125" class="t s1_125">N0 </span><span id="ta_125" class="t s3_125">No regional lymph node metastasis </span>
<span id="tb_125" class="t s1_125">N1 </span><span id="tc_125" class="t s3_125">Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and </span>
<span id="td_125" class="t s2_125">ENE(−) </span>
<span id="te_125" class="t s1_125">N2 </span><span id="tf_125" class="t s3_125">Metastasis in a single ipsilateral node larger than 3 cm but not larger than 6 cm in </span>
<span id="tg_125" class="t s3_125">greatest dimension and ENE(–); </span><span id="th_125" class="t s4_125">or </span><span id="ti_125" class="t s3_125">metastases in multiple ipsilateral lymph nodes, none </span>
<span id="tj_125" class="t s2_125">larger than 6 cm in greatest dimension and ENE(−); </span>
<span id="tk_125" class="t s4_125">or </span><span id="tl_125" class="t s3_125">in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension </span>
<span id="tm_125" class="t s2_125">and ENE(−) </span>
<span id="tn_125" class="t s3_125">N2a </span><span id="to_125" class="t s3_125">Metastasis in a single ipsilateral node larger than 3 cm but not larger than 6 cm in </span>
<span id="tp_125" class="t s2_125">greatest dimension and ENE(−) </span>
<span id="tq_125" class="t s3_125">N2b </span><span id="tr_125" class="t s3_125">Metastases in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension </span>
<span id="ts_125" class="t s2_125">and ENE(−) </span>
<span id="tt_125" class="t s3_125">N2c </span><span id="tu_125" class="t s3_125">Metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest </span>
<span id="tv_125" class="t s2_125">dimension and ENE(−) </span>
<span id="tw_125" class="t s1_125">N3 </span><span id="tx_125" class="t s2_125">Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(−); </span>
<span id="ty_125" class="t s4_125">or </span><span id="tz_125" class="t s2_125">metastasis in any node(s) and clinically overt ENE(+) </span>
<span id="t10_125" class="t s3_125">N3a </span><span id="t11_125" class="t s2_125">Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(−) </span>
<span id="t12_125" class="t s3_125">N3b </span><span id="t13_125" class="t s2_125">Metastasis in any node(s) and clinically overt ENE(+) </span>
<span id="t14_125" class="t s5_125">Note: </span><span id="t15_125" class="t s6_125">A designation of “U” or “L” may be used for any N category to indicate metastasis above the lower border </span>
<span id="t16_125" class="t s6_125">of the cricoid (U) or below the lower border of the cricoid (L). </span>
<span id="t17_125" class="t s7_125">Similarly, clinical and pathological ENE should be recorded as ENE(−) or ENE(+). </span>
<span id="t18_125" class="t s6_125">Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition </span>
<span id="t19_125" class="t s6_125">(2017) published by Springer International Publishing. (For complete information and data supporting the staging tables, visit </span><span id="t1a_125" class="t s8_125">www.springer.com</span><span id="t1b_125" class="t s6_125">.) </span>
<span id="t1c_125" class="t s9_125">Continued </span>
<span id="t1d_125" class="t sa_125">NCCN Guidelines Version 4.2024 </span>
<span id="t1e_125" class="t sa_125">Head and Neck Cancers </span>
<span id="t1f_125" class="t sb_125">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t1g_125" class="t sc_125">® </span>
<span id="t1h_125" class="t sb_125">(NCCN </span>
<span id="t1i_125" class="t sc_125">® </span>
<span id="t1j_125" class="t sb_125">), All rights reserved. NCCN Guidelines </span>
<span id="t1k_125" class="t sc_125">® </span>
<span id="t1l_125" class="t sb_125">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t1m_125" class="t sd_125">NCCN Guidelines Index </span>
<span id="t1n_125" class="t sd_125">Table of Contents </span>
<span id="t1o_125" class="t sd_125">Discussion </span>
<span id="t1p_125" class="t s1_125">ST-5 </span>
<span id="t1q_125" class="t se_125">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
